Bruce, D S <br/><br/>
Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.  [electronic resource] 

 -  Transplantation  Nov 2001 
 - 1637-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/00007890-200111270-00010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Daclizumab<br/>Female<br/>Graft Rejection<br/>Graft Survival<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Immunosuppression Therapy<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Pancreas Transplantation--adverse effects<br/>Retrospective Studies<br/>Survival Rate<br/>Tacrolimus--therapeutic use